Clinical Trial Update: Anakinra for Preterm Infants Pilot [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 pilot trial of the IL-1 receptor antagonist anakinra in extremely preterm infants is ongoing and currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Preterm Birth

Drugs mentioned

• Anakinra (anakinra)

Snippet

Sponsor: Monash Medical Centre | Conditions: Prematurity; Extreme, Inflammation | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING